Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
London School of Hygiene & Tropical Medicine
RC000330
Keppel Street,
London
WC1E 7HT
UK
Contact person: Paul Pester
Telephone: +44 02079272471
E-mail: paul.pester@lshtm.ac.uk
NUTS: UKI31
Internet address(es)
Main address: http://www.lshtm.ac.uk
Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/104519
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
Reference number: LSHTM-2021-29
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1 066 444.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33141310
33141320
33621000
33621200
33698000
39299100
44617100
79920000
II.2.3) Place of performance
NUTS code:
UKI31
Main site or place of performance:
LSHTM - Keppel Street, London WC1A 7HT
II.2.4) Description of the procurement
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
II.2.5) Award criteria
Quality criterion: Technical
/ Weighting: 70
Price
/ Weighting:
30
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2021/S 000-029090
Section V: Award of contract
Contract No: 1
Title: Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
10/08/2023
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Sharp Clinical Services (UK) Ltd
2234557
Unit 28, Heol Klockner
Rhymney
NP22 5RL
UK
E-mail: Rachel.curran@sharpclinical.com
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1 066 444.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
The Royal Courts of Justice
The Strand
London
WC2A 2LL
UK
VI.4.4) Service from which information about the review procedure may be obtained
London School of Hygiene & Tropical Medicine
Keppel Street
London
WC1E 7HT
UK
E-mail: procurement@lshtm.ac.uk
VI.5) Date of dispatch of this notice
21/08/2023